These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Effect of CFTR modulator therapy with elexacaftor/tezacaftor/ivacaftor on pulmonary ventilation derived by 3D phase-resolved functional lung MRI in cystic fibrosis patients. Klimeš F; Voskrebenzev A; Gutberlet M; Speth M; Grimm R; Dohna M; Hansen G; Wacker F; Renz DM; Dittrich AM; Vogel-Claussen J Eur Radiol; 2024 Jan; 34(1):80-89. PubMed ID: 37548691 [TBL] [Abstract][Full Text] [Related]
15. A dual center and dual vendor comparison study of automated perfusion-weighted phase-resolved functional lung magnetic resonance imaging with dynamic contrast-enhanced magnetic resonance imaging in patients with cystic fibrosis. Behrendt L; Smith LJ; Voskrebenzev A; Klimeš F; Kaireit TF; Pöhler GH; Kern AL; Gonzalez CC; Dittrich AM; Marshall H; Schütz K; Hughes PJC; Ciet P; Tiddens HAWM; Wild JM; Vogel-Claussen J Pulm Circ; 2022 Apr; 12(2):e12054. PubMed ID: 35514781 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of perfusion-weighted phase-resolved functional lung magnetic resonance imaging in patients with chronic pulmonary embolism. Duan J; Xie S; Sun H; An J; Li H; Li L; Grimm R; Voskrebenzev A; Vogel-Claussen J Front Med (Lausanne); 2023; 10():1256925. PubMed ID: 37822465 [TBL] [Abstract][Full Text] [Related]